RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
Go back to RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease| Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) | Delayed: 5.83 +0.26 (4.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $5.95 | |||
| Open | $5.59 | 52 Week Low | $4.20 | |||
| Day High | $5.95 | P/E | 97.17 | |||
| Day Low | $5.50 | EPS | $0.06 | |||
| Volume | 51,660 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.93 +0.09 (10.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $16.54 | |||
| Open | $0.84 | 52 Week Low | $8.10 | |||
| Day High | $0.94 | P/E | N/A | |||
| Day Low | $0.83 | EPS | $0.00 | |||
| Volume | 126,476 | |||||
